Compass Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Toledano Miranda Jayne | — | Other | 1,791,549 | — | — | 1,791,549 | Jun 25, 2021 |
| ORBIMED ADVISORS LLC | — | Purchase | 1,455,132 | $5.00 | $7,275,660 | 12,714,404 | Jun 19, 2020 |
| GORDON CARL L | — | Purchase | 1,455,132 | $5.00 | $7,275,660 | 12,714,404 | Jun 19, 2020 |
| Ferneau Philip | — | Purchase | 250,000 | $5.00 | $1,250,000 | 400,280 | Jun 19, 2020 |
| Schuetz Thomas J. | Chief Executive Officer | Purchase | 97,431 | $5.00 | $487,155 | 4,525,467 | Jun 19, 2020 |
| Sunderland Julie | — | Purchase | 289,118 | $5.00 | $1,445,590 | 2,502,025 | Jun 19, 2020 |